Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Woodhead (Manchester, United Kingdom). Community acquired pneumonia guidelines: not only treatment indications. Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis

Member's Comments

No comment yet.

Related content which might interest you: Community acquired and health-care associated pneumonia: Should we own follow guidelines? Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Community acquired pneumonia in Greece: Clinical, microbiological data and adherence to the IDSA guidelines Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 From international guidelines to local guidelines for nosocomial pneumonia: what is missing? Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution Year: 2019 Community acquired pneumonia in Greece: clinical, laboratory data – adherence to the international guidelines Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 CAP and HAP guidelines: treatment indications and more Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines Source: Eur Respir J 2003 Dec 01;22(6):876-882 Year: 2003 Local antibiotic guidelines for management of adult community acquired pneumonia in UK hospitals Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Developing outcome-based guidelines in CAP and AECB Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines? Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017 Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003 Clinical effectiveness of recommended antibiotics in COVID19 pneumonias; assessing national referral centre guidance Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice. Source: International Congress 2017 – COPD management Year: 2017 In-hospital mortality for community acquired pneumonia and evaluation according to national diagnosis and treatment guidelines Source: Eur Respir J 2004; 24: Suppl. 48, 187s Year: 2004 Management of community acquired pneumonia in UK hospitals: a survey of the availability of local guidelines and severity assessment tools Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia Source: Eur Respir J 2007; 29: 751-756 Year: 2007 Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Source: Eur Respir J 2011; 38: 878-887 Year: 2011 Management of community-acquired pneumonia: new evidence-based algorithms. Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021